1 / 7

The endocannabinoid system

The endocannabinoid system The endocannabinoid system is a modulatory system Endocannabinoids: Synthesized on demand from lipid precursors in postsynaptic cell Activate CB 1 receptors presynaptically, then degrade immediately Act as retrograde messengers

jaden
Download Presentation

The endocannabinoid system

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The endocannabinoid system

  2. The endocannabinoid system is a modulatory system • Endocannabinoids: • Synthesized on demand from lipid precursors in postsynaptic cell • Activate CB1 receptors presynaptically, then degrade immediately • Act as retrograde messengers • Inhibit neurotransmitter release • CB1 receptors: • Play a key role in energy balance and lipid and glucose metabolism Di Marzo V, Matias I. Nature Neurosci. 2005;8:585-589.Di Marzo V, Melck D, et al. Trends Neurosci. 1998;21:521-528.Wilson RI, Nicholl RA. Science. 2002;296:678-682.

  3. Feeding activity ECS Central endocannabinoid system activity modulates animal feeding behaviour • Food deprivation raises and feeding lowers hypothalamic endocannabinoid levels1 • CB1 receptor deletion or antagonism blunts refeeding behaviour in fasted animals2 • Endocannabinoid injections into the ventromedial nucleus of the hypothalamus3 or the nucleus accumbens promotes feeding in satiated animals, which is blocked by rimonabant ECS: endocannabinoid system Kirkham TC, et al. Br J Pharmacol. 2002;136:550-557.Di Marzo V, et al. Nature. 2001;410:822-825.Jamshidi N, et al. Br J Pharmacol. 2001;134:1151-1154.

  4. Brain Peripheral tissues Adipose Liver Muscle tissue GI tract Hypothalamus: Nucleus accumbens: ^ ^ hunger motivation to eat Insulin resistance ^ HDL-cholesterol Triglycerides ^ Increased food intake Glucose uptake Increased fat storage Adiponectin Central and peripheral targets of the endocannabinoid system and effects of overactivity HDL: high-density lipoprotein Bensaid M, Gary-Bobo M, etal. Mol Pharmacol. 2003;63:908-914.Pagotto U, Vicennati V, et al. Ann Med. 2005;37:270-275.Osei-Hyiaman D, DePetrillo M, et al. J Clin Invest. 2005;115:1298-1305.Di Marzo V, Matias I. Nature Neurosci. 2005;8:585-589.Liu YL, Connoley IP, et al. Int J Obes Relat Metab Disord. 2005;29:183-187.

  5. Sites of CB1 receptors and potential effects of CB1 receptor blockade Di Marzo M, etal. Nature. 2001;410:822-825.Ravinet Trillou C, Arnone M, et al. Am J Physiol Regul Integr Comp Physiol. 2003;284:R345-353.Cota D, Marsicano G, et al. Int J Obes Relat Metab Disord. 2003;27:289-301.Pagotto U, Pasquali R. Lancet. 2005;365:1363-1364.Van Gaal L, et al. Lancet. 2005;365:1389-1397.Liu YL, et al. Int J Obes Relat Metab Disord.2005;29:183-187.Osei-Hyiaman D, DePetrillo, et al. Clin Invest. 2005;115:1298-1305.Massa F, et al.J Mol Med. 2005;83:944-954.

  6.  SREBP1c High fat diet AEA*  CB1R  FA synthase  AcCoA cbxlase  FA oxidation  FA synthesis *Anandamide  Hepatic lipid content  VLDL production  Insulin resistance  Triglyceride flux CB1 blockade Hepatic endocannabinoid system dysregulation promotes hepatic lipogenesis and insulin resistance in diet-induce obesity mice Osei-Hyiaman D, et al. J Clin Invest, 2005:115:1298-1305.

  7. Feeding ECS CB-1 blockade Weight Dyslipidaemia Type 2 diabetes Peripheral insulinresistance Hepatic insulinresistance Hepaticglucoseoutput Small,denseLDL-C LowHDL-C CETP,lipolysis Adiponectin Lipolysis FFA TG-richVLDL-C FFA Portal circulation ECS Liver Visceral fat ECS CB-1 blockade CB-1 blockade Central/peripheral endocannabinoid system dysregulation leads to weight-dependent and direct effects by CB1 blockade Weight-dependent Weight Independent Endocannabinoid system ECS Modified from: Lam TK, et al. Am J Physiol Endocrinol Metab. 2003;284:E863-8673. Carr D, et al. Diabetes. 2004 Aug;53(8):2087-2094. Eckel R, et al. Lancet. 2005;365(9468):1415-1428. Pagotto U, Pasquali R. Lancet. 2005;365:1363-1364. Di Marzo V, Matias I. Nature Neuroscience. 2005;8:585-589. FFA=free fatty acids CETP=cholesterol ester transfer protein

More Related